• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迟发性非典型泛酸激酶相关神经变性

Late onset atypical pantothenate-kinase-associated neurodegeneration.

作者信息

Diaz Natalie

机构信息

Los Angeles Biomedical Institute, Harbor-UCLA Medical Center, Box No. 492, 1000 W. Carson Street, Los Angeles, Torrance, CA 90509, USA.

出版信息

Case Rep Neurol Med. 2013;2013:860201. doi: 10.1155/2013/860201. Epub 2013 Mar 24.

DOI:10.1155/2013/860201
PMID:23634310
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3619544/
Abstract

Introduction. Pantothenate-kinase-associated neurodegeneration (PKAN) is a rare genetic disease and a form of neurodegeneration with brain iron accumulation (NBIA). It most commonly begins in the first two decades of life but should be considered in the differential diagnosis of patients at any age with an atypical progressive extrapyramidal disorder and cognitive impairment. Few late-adult cases have been reported. Case Report. A 50-year-old woman presented with a history of progressive dysarthria and dysphagia secondary to orolingual dystonia. Initial work-up was normal. There was no family history. Her initial symptoms were followed by the onset of blepharospasm, cervical dystonia, Parkinsonism, and cognitive impairment. Follow-up MRI four years after presentation revealed the diagnostic "eye-of-the-tiger" sign. Genetic testing confirmed a homozygous missense mutation consistent with the diagnosis of PKAN. Conclusion. Although PKAN is a rare genetic disorder most commonly seen in childhood, it should be considered in adult patients with a history of progressive focal dystonia or atypical Parkinsonism. As the radiographic findings are quite characteristic, genetic testing should be performed if the MRI shows evidence of iron accumulation. Optimal treatment strategies are not known, and at the current time therapies should be directed at the specific manifestations of the disease.

摘要

引言。泛酸激酶相关神经变性(PKAN)是一种罕见的遗传疾病,也是脑铁沉积神经变性(NBIA)的一种形式。它最常始于生命的前二十年,但对于任何年龄患有非典型进行性锥体外系疾病和认知障碍的患者,在鉴别诊断时都应考虑该病。很少有老年病例的报道。病例报告。一名50岁女性,有口面部肌张力障碍继发的进行性构音障碍和吞咽困难病史。初始检查结果正常。无家族史。在其初始症状之后,出现了眼睑痉挛、颈部肌张力障碍、帕金森综合征和认知障碍。就诊四年后的随访磁共振成像(MRI)显示出诊断性的“虎眼征”。基因检测证实存在一个与PKAN诊断相符的纯合错义突变。结论。尽管PKAN是一种罕见的遗传疾病,最常见于儿童期,但对于有进行性局灶性肌张力障碍或非典型帕金森综合征病史的成年患者也应考虑该病。由于影像学表现颇具特征性,如果MRI显示有铁沉积证据,应进行基因检测。目前尚不清楚最佳治疗策略,目前的治疗应针对疾病的具体表现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/3619544/a70abe81982e/CRIM.NM2013-860201.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/3619544/a70abe81982e/CRIM.NM2013-860201.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb49/3619544/a70abe81982e/CRIM.NM2013-860201.001.jpg

相似文献

1
Late onset atypical pantothenate-kinase-associated neurodegeneration.迟发性非典型泛酸激酶相关神经变性
Case Rep Neurol Med. 2013;2013:860201. doi: 10.1155/2013/860201. Epub 2013 Mar 24.
2
Novel homozygous PANK2 mutation causing atypical pantothenate kinase-associated neurodegeneration (PKAN) in a Cypriot family.在一个塞浦路斯家族中发现导致非典型泛酸激酶相关神经变性(PKAN)的新型纯合PANK2突变。
J Neurol Sci. 2014 May 15;340(1-2):233-6. doi: 10.1016/j.jns.2014.03.001. Epub 2014 Mar 11.
3
The first Vietnamese patient who presented late onset of pantothenate kinase-associated neurodegeneration diagnosed by whole exome sequencing: A case report.首例全外显子测序诊断的晚发性泛酸激酶相关神经变性越南患者:病例报告。
Medicine (Baltimore). 2023 Oct 27;102(43):e34853. doi: 10.1097/MD.0000000000034853.
4
A Novel PANK2 Mutation in a Patient with Atypical Pantothenate-Kinase-Associated Neurodegeneration Presenting with Adult-Onset Parkinsonism.一个具有非典型泛酸激酶相关神经退行性变的成年发病型帕金森病患者中发现的 PANK2 基因突变。
J Clin Neurol. 2009 Dec;5(4):192-4. doi: 10.3988/jcn.2009.5.4.192. Epub 2009 Dec 31.
5
Neurodegeneration with brain iron accumulation: A case report.伴脑铁沉积的神经退行性变:一例报告。
Dement Neuropsychol. 2016 Apr-Jun;10(2):160-164. doi: 10.1590/S1980-5764-2016DN1002014.
6
Treatment of Pantothenate-Kinase Neurodegeneration With Baclofen, Botulinum Toxin, and Deferiprone: A Case Report.用巴氯芬、肉毒杆菌毒素和去铁酮治疗泛酸激酶神经变性:一例报告
Brain Neurorehabil. 2023 Sep 25;16(3):e25. doi: 10.12786/bn.2023.16.e25. eCollection 2023 Nov.
7
Pantothenate Kinase-Associated Neurodegeneration泛酸激酶相关神经变性
8
Clinical Heterogeneity of Atypical Pantothenate Kinase-Associated Neurodegeneration in Koreans.韩国人中非典型泛酸激酶相关神经退行性变的临床异质性。
J Mov Disord. 2016 Jan;9(1):20-7. doi: 10.14802/jmd.15058. Epub 2016 Jan 25.
9
Patient and caregiver experiences with pantothenate kinase-associated neurodegeneration (PKAN): results from a patient community survey.患者和照护者对泛酸激酶相关神经退行性变(PKAN)的体验:来自患者社区调查的结果。
Orphanet J Rare Dis. 2023 Aug 31;18(1):257. doi: 10.1186/s13023-023-02869-1.
10
Adult-onset case of undiagnosed neurodegeneration with brain iron accumulation with psychotic symptoms.一例成年起病、未确诊的伴有脑铁沉积及精神病性症状的神经退行性疾病。
Case Rep Psychiatry. 2014;2014:742042. doi: 10.1155/2014/742042. Epub 2014 May 20.

引用本文的文献

1
Treatment of Pantothenate-Kinase Neurodegeneration With Baclofen, Botulinum Toxin, and Deferiprone: A Case Report.用巴氯芬、肉毒杆菌毒素和去铁酮治疗泛酸激酶神经变性:一例报告
Brain Neurorehabil. 2023 Sep 25;16(3):e25. doi: 10.12786/bn.2023.16.e25. eCollection 2023 Nov.
2
Pantothenate Kinase-Associated Neurodegeneration (PKAN) With Concomitant Blepharospasm: Unveiling a Clinical Enigma.伴眼睑痉挛的泛酸激酶相关神经变性(PKAN):揭示一个临床谜团。
Cureus. 2023 Oct 8;15(10):e46665. doi: 10.7759/cureus.46665. eCollection 2023 Oct.
3
Potpourri of retinopathies in rare eye disease - A case series.

本文引用的文献

1
Metabolic consequences of mitochondrial coenzyme A deficiency in patients with PANK2 mutations.PANK2 基因突变患者中线粒体辅酶 A 缺乏的代谢后果。
Mol Genet Metab. 2012 Mar;105(3):463-71. doi: 10.1016/j.ymgme.2011.12.005. Epub 2011 Dec 14.
2
The "eye-of-the-tiger" sign may be absent in the early stages of classic pantothenate kinase associated neurodegeneration.在典型的泛酸激酶相关神经变性的早期阶段,“虎眼征”可能不存在。
Neuropediatrics. 2011 Aug;42(4):159-62. doi: 10.1055/s-0031-1285925. Epub 2011 Aug 29.
3
A pilot trial of deferiprone for neurodegeneration with brain iron accumulation.
多种视网膜病变的罕见眼病病例系列报告。
Indian J Ophthalmol. 2022 Jul;70(7):2605-2609. doi: 10.4103/ijo.IJO_3002_21.
4
Identification of a novel mutation in associated with a complicated form of hereditary spastic paraplegia.与一种复杂形式的遗传性痉挛性截瘫相关的新型突变的鉴定。
Neurol Genet. 2020 Sep 8;6(5):e514. doi: 10.1212/NXG.0000000000000514. eCollection 2020 Oct.
5
Mitochondrial Dysfunction, Oxidative Stress and Neuroinflammation in Neurodegeneration with Brain Iron Accumulation (NBIA).脑铁沉积神经退行性疾病(NBIA)中的线粒体功能障碍、氧化应激与神经炎症
Antioxidants (Basel). 2020 Oct 20;9(10):1020. doi: 10.3390/antiox9101020.
6
Treatment Responsiveness of Parkinsonism in Atypical Pantothenate Kinase-Associated Neurodegeneration.非典型泛酸激酶相关神经变性中帕金森症的治疗反应性
Mov Disord Clin Pract. 2020 Sep 29;7(Suppl 3):S71-S73. doi: 10.1002/mdc3.13056. eCollection 2020 Sep.
7
The Case of a Patient with Pantothenate Kinase-Associated Neurodegeneration Presenting with a Prolonged History of Stuttering Speech and a Misdiagnosis of Parkinson's Disease.
J Mov Disord. 2021 Jan;14(1):86-88. doi: 10.14802/jmd.20062. Epub 2020 Sep 21.
8
Parkinson's Disease and Metal Storage Disorders: A Systematic Review.帕金森病与金属储存障碍:一项系统评价。
Brain Sci. 2018 Oct 31;8(11):194. doi: 10.3390/brainsci8110194.
9
Novel mutations in PANK2 and PLA2G6 genes in patients with neurodegenerative disorders: two case reports.神经退行性疾病患者PANK2和PLA2G6基因的新突变:两例病例报告。
BMC Med Genet. 2017 Aug 18;18(1):87. doi: 10.1186/s12881-017-0439-y.
10
Neurodegeneration with Brain Iron Accumulation.脑铁蓄积性神经退行性变。
Curr Neurol Neurosci Rep. 2016 Jan;16(1):9. doi: 10.1007/s11910-015-0608-3.
去铁酮治疗脑铁蓄积性神经退行性变的初步试验。
Haematologica. 2011 Nov;96(11):1708-11. doi: 10.3324/haematol.2011.043018. Epub 2011 Jul 26.
4
Adult onset Hallervorden-Spatz disease with psychotic symptoms.伴有精神病性症状的成人起病型哈勒沃登-施帕茨病
Actas Esp Psiquiatr. 2011 Jul-Aug;39(4):260-2. Epub 2011 Jul 1.
5
Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: results of a phase II pilot trial.泛酸激酶相关神经退行性变(PKAN)患者接受地拉罗司治疗后的铁相关 MRI 图像:一项 II 期试点试验结果。
Mov Disord. 2011 Aug 1;26(9):1756-9. doi: 10.1002/mds.23751. Epub 2011 May 6.
6
Indian-subcontinent NBIA: unusual phenotypes, novel PANK2 mutations, and undetermined genetic forms.印度次大陆 NBIA:不常见的表型、新型 PANK2 突变和未确定的遗传形式。
Mov Disord. 2010 Jul 30;25(10):1424-31. doi: 10.1002/mds.23095.
7
A Novel PANK2 Mutation in a Patient with Atypical Pantothenate-Kinase-Associated Neurodegeneration Presenting with Adult-Onset Parkinsonism.一个具有非典型泛酸激酶相关神经退行性变的成年发病型帕金森病患者中发现的 PANK2 基因突变。
J Clin Neurol. 2009 Dec;5(4):192-4. doi: 10.3988/jcn.2009.5.4.192. Epub 2009 Dec 31.
8
Pallidal stimulation for pantothenate kinase-associated neurodegeneration dystonia.苍白球刺激术治疗泛酸激酶相关神经变性性肌张力障碍
Arch Dis Child. 2008 Mar;93(3):239-40. doi: 10.1136/adc.2007.118968.
9
Eye of the tiger sign in multiple system atrophy.多系统萎缩中的“虎眼征”
Eur J Neurol. 2007 Nov;14(11):e1-2. doi: 10.1111/j.1468-1331.2007.01925.x.
10
Deprivation of pantothenic acid elicits a movement disorder and azoospermia in a mouse model of pantothenate kinase-associated neurodegeneration.在泛酸激酶相关神经变性的小鼠模型中,泛酸缺乏会引发运动障碍和无精子症。
J Inherit Metab Dis. 2007 Jun;30(3):310-7. doi: 10.1007/s10545-007-0560-8. Epub 2007 Apr 12.